{"id":"https://openalex.org/W7235313232","doi":"https://doi.org/10.57264/cer-2026-0104","title":"Mortality and inpatient hospitalizations by anti-plasma cell dyscrasia treatment patterns among patients with cardiac light chain amyloidosis: results from a US administrative claims database","display_name":"Mortality and inpatient hospitalizations by anti-plasma cell dyscrasia treatment patterns among patients with cardiac light chain amyloidosis: results from a US administrative claims database","alternate_titles":[],"publication_year":2026,"publication_date":"2026-11-17","ids":{"openalex":"https://openalex.org/W7235313232","doi":"https://doi.org/10.57264/cer-2026-0104","pmid":"https://pubmed.ncbi.nlm.nih.gov/43043879"},"language":"en","primary_location":{"id":"doi:10.57264/cer-2026-0104","doi":"https://doi.org/10.57264/cer-2026-0104","is_oa":true,"landing_page_url":"https://doi.org/10.57264/cer-2026-0104","pdf_url":null,"source":{"id":"https://openalex.org/S2489859990","display_name":"Journal of Comparative Effectiveness Research","issn_l":"2042-6305","issn":["2042-6305","2042-6313"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Comparative Effectiveness Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7235313232"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.57264/cer-2026-0104","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012152259","display_name":"Jeffrey E. Thompson","orcid":"https://orcid.org/0009-0007-6808-8511","observed_orcids":["https://orcid.org/0009-0007-6808-8511"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeffrey Thompson","raw_affiliation_strings":["Global Health Economics & Outcomes Research, Alexion, AstraZeneca Rare Disease, Boston, MA 02210, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Health Economics & Outcomes Research, Alexion, AstraZeneca Rare Disease, Boston, MA 02210, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5162579785","display_name":"Clifton Chow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Clifton Chow","raw_affiliation_strings":["Department of Psychiatry, Harvard Medical School, Boston, MA 02115, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Harvard Medical School, Boston, MA 02115, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087195983","display_name":"Julia Catini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Julia Catini","raw_affiliation_strings":["Global Medical Affairs, Alexion, AstraZeneca Rare Disease, Wilmington, DE 19803, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medical Affairs, Alexion, AstraZeneca Rare Disease, Wilmington, DE 19803, USA","institution_ids":["https://openalex.org/I4210150756"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"e260104","last_page":"e260104"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11638","display_name":"Cardiac tumors and thrombi","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/daratumumab","display_name":"daratumumab","score":0.953000009059906},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.8899999856948853},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.8849999904632568},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.9070000052452087},{"id":"https://openalex.org/keywords/renal-involvement","display_name":"renal involvement","score":0.8019999861717224},{"id":"https://openalex.org/keywords/cardiomyopathy","display_name":"cardiomyopathy","score":0.7400000095367432},{"id":"https://openalex.org/keywords/healthcare-resource-utilization","display_name":"healthcare resource utilization","score":0.7829999923706055},{"id":"https://openalex.org/keywords/newly-diagnosed-patients","display_name":"newly diagnosed patients","score":0.703000009059906}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9611999988555908},{"id":"https://openalex.org/C2780411336","wikidata":"https://www.wikidata.org/wiki/Q1706485","display_name":"Plasma cell dyscrasia","level":4,"score":0.6992999911308289},{"id":"https://openalex.org/C179755657","wikidata":"https://www.wikidata.org/wiki/Q58702","display_name":"Mortality rate","level":2,"score":0.5421000123023987},{"id":"https://openalex.org/C2777607188","wikidata":"https://www.wikidata.org/wiki/Q5038315","display_name":"Cardiac amyloidosis","level":3,"score":0.5407999753952026},{"id":"https://openalex.org/C113775271","wikidata":"https://www.wikidata.org/wiki/Q3709969","display_name":"Dyscrasia","level":4,"score":0.5266000032424927},{"id":"https://openalex.org/C2779951007","wikidata":"https://www.wikidata.org/wiki/Q816798","display_name":"Amyloidosis","level":2,"score":0.5042999982833862},{"id":"https://openalex.org/C2781119759","wikidata":"https://www.wikidata.org/wiki/Q5222113","display_name":"Daratumumab","level":4,"score":0.49380001425743103},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45489999651908875},{"id":"https://openalex.org/C2779551797","wikidata":"https://www.wikidata.org/wiki/Q4652470","display_name":"AL amyloidosis","level":4,"score":0.392300009727478},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.382099986076355},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3813999891281128},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.36739999055862427},{"id":"https://openalex.org/C2778704086","wikidata":"https://www.wikidata.org/wiki/Q693058","display_name":"Chest pain","level":2,"score":0.33649998903274536},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.30480000376701355},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.28999999165534973},{"id":"https://openalex.org/C2778797674","wikidata":"https://www.wikidata.org/wiki/Q847583","display_name":"Cardiomyopathy","level":3,"score":0.28760001063346863},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.2831000089645386},{"id":"https://openalex.org/C2778964538","wikidata":"https://www.wikidata.org/wiki/Q2090167","display_name":"Plasmacytoma","level":3,"score":0.27160000801086426},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.2696000039577484},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.2565999925136566},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.250900000333786}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.57264/cer-2026-0104","doi":"https://doi.org/10.57264/cer-2026-0104","is_oa":true,"landing_page_url":"https://doi.org/10.57264/cer-2026-0104","pdf_url":null,"source":{"id":"https://openalex.org/S2489859990","display_name":"Journal of Comparative Effectiveness Research","issn_l":"2042-6305","issn":["2042-6305","2042-6313"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Comparative Effectiveness Research","raw_type":"journal-article"},{"id":"pmid:43043879","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/43043879","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of comparative effectiveness research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.57264/cer-2026-0104","doi":"https://doi.org/10.57264/cer-2026-0104","is_oa":true,"landing_page_url":"https://doi.org/10.57264/cer-2026-0104","pdf_url":null,"source":{"id":"https://openalex.org/S2489859990","display_name":"Journal of Comparative Effectiveness Research","issn_l":"2042-6305","issn":["2042-6305","2042-6313"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Comparative Effectiveness Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W1976378675","https://openalex.org/W2050187883","https://openalex.org/W2113807585","https://openalex.org/W2966062113","https://openalex.org/W2975911854","https://openalex.org/W3036329541","https://openalex.org/W3081137277","https://openalex.org/W3134745397","https://openalex.org/W3169713752","https://openalex.org/W3174070807","https://openalex.org/W3187630480","https://openalex.org/W4226365437","https://openalex.org/W4283011468","https://openalex.org/W4292327205","https://openalex.org/W4307200807","https://openalex.org/W4309336603","https://openalex.org/W4309337045","https://openalex.org/W4311022327","https://openalex.org/W4408281736","https://openalex.org/W4409292261"],"related_works":["https://openalex.org/W4412805984","https://openalex.org/W4404571954","https://openalex.org/W4414303082","https://openalex.org/W4417018386","https://openalex.org/W7168113622","https://openalex.org/W4389229131","https://openalex.org/W3095729678","https://openalex.org/W4389778097","https://openalex.org/W4380794487","https://openalex.org/W7162625408"],"abstract_inverted_index":{"Aim:":[0],"To":[1],"gain":[2],"insights":[3],"into":[4],"real-world":[5,32],"mortality":[6,33,134,162,188,205],"and":[7,37,86,135,147,163,172,189,198,206,224,230,235,245,262,271],"hospitalization":[8,38,137,165,191,208],"among":[9,39,139,210,241,256,266,275],"newly":[10,42],"diagnosed":[11,43],"patients":[12,41,116,141,211,242,257,267],"with":[13,44,47,117,160,186,212,243,258,268,277],"light":[14],"chain":[15],"(AL)":[16],"amyloidosis":[17,46,73,120],"initiating":[18],"anti-plasma":[19],"cell":[20],"dyscrasia":[21],"treatment.":[22],"Materials":[23],"&":[24],"methods:":[25],"This":[26],"retrospective,":[27],"noninterventional,":[28],"observational":[29],"study":[30,125],"evaluated":[31],"by":[34,106],"treatment":[35,58],"patterns":[36,253],"adult":[40],"AL":[45,72,119,259],"cardiomyopathy":[48],"in":[49,74,123],"the":[50,75,79,94],"US":[51],"IQVIA":[52],"PharMetrics":[53],"claims":[54],"database.":[55],"Data":[56],"from":[57],"initiation":[59],"(index":[60],"date)":[61],"to":[62,78],"365":[63],"days":[64],"postindex":[65],"were":[66,82,91,121,142,219,264],"evaluated.":[67],"Patients":[68],"receiving":[69],"treatments":[70],"for":[71,156,182],"year":[76],"prior":[77],"index":[80],"date":[81],"excluded.":[83],"AL-,":[84],"cardiac-,":[85],"cardiac/renal-related":[87],"healthcare":[88],"resource":[89],"utilization":[90],"assigned":[92],"using":[93],"International":[95],"Classification":[96],"of":[97,114,145,150,167,170,175,193,196,201,222,227,233,238],"Diseases,":[98],"Tenth":[99],"Revision":[100],".":[101],"Summary":[102],"statistics":[103],"are":[104],"reported":[105],"cardiac":[107,118,214,244,270,279],"or":[108],"cardiac/renal":[109],"involvement.":[110,280],"Results:":[111],"A":[112],"total":[113],"198":[115],"included":[122],"this":[124],"(mean":[126],"age,":[127],"64.8":[128],"years;":[129],"70.7%":[130],"male).":[131],"The":[132],"1-year":[133,161,187],"condition-related":[136,164,190,207],"rates":[138,166,192,209],"all":[140],"9.1%":[143],"(18":[144],"198)":[146],"65.7%":[148],"(130":[149],"198),":[151],"respectively.":[152,177,203],"Daratumumab":[153,178],"was":[154,179],"prescribed":[155,181],"138":[157],"(69.7%)":[158],"patients,":[159,185],"7.2%":[168],"(10":[169],"138)":[171],"67.4%":[173],"(93":[174],"138),":[176],"not":[180],"60":[183],"(30.3%)":[184],"13.3%":[194],"(8":[195],"60)":[197],"61.7%":[199],"(37":[200],"60),":[202],"One-year":[204],"only":[213,278],"involvement":[215,247,273],"(n":[216,248],"=":[217,249],"66)":[218,223],"7.6%":[220],"(5":[221],"45.5%":[225],"(30":[226],"66),":[228],"respectively,":[229,240],"9.8%":[231],"(13":[232],"132)":[234],"75.8%":[236],"(100":[237],"132),":[239],"renal":[246,272],"132).":[250],"Conclusion:":[251],"Treatment":[252],"varied":[254],"considerably":[255],"amyloidosis.":[260],"Mortality":[261],"hospitalizations":[263],"higher":[265],"both":[269],"than":[274],"those":[276]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7235313232","counts_by_year":[],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2026-11-18T00:00:00"}
